The Enhanced Games, a controversial sports competition that allows athletes to use performance-enhancing drugs banned in traditional sports, has ended its first event with disappointing results both competitively and financially.
Held in Las Vegas in May, the Games attracted backing from figures including Peter Thiel and executives from the crypto, AI and biotech industries. However, only one world record was set during the event, in swimming.
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
Enhanced Group, the company behind the Games, has now reported a net loss of nearly $62 million for the second quarter, with a significant portion of the loss linked to hosting the competition.
Revenue Driven By The Games
Founded in 2023, Enhanced Group went public earlier this year at a valuation of around $1.2 billion. Its core business is a digital telehealth platform offering personalised health treatments, including FDA-approved peptides, testosterone injections and GLP-1 drugs.
The company generated $17.7 million in revenue during the second quarter, but most of it came from sponsorships connected to the Games rather than its telehealth business.
The results also raise questions about plans to make the competition an annual event, as repeating a loss-making format could prove difficult without significantly higher revenue.
A Lower-Cost Strategy
Enhanced Group recently launched Enhanced Breakers, an online sports series that it says operates at a fraction of the cost of a full Games event. The format is designed to keep athletes competing and sponsors engaged while promoting the company’s performance-medicine business throughout the year.
Meanwhile, the broader peptide and performance-medicine industry continues to grow. Silicon Valley has become a hub for startups focused on biohacking and personalised health, while the sector is expanding faster than the regulations governing it.
